110 views0 answers0 votes
148 views0 answers0 votes
A systematic review of 416 medical journal articles affirmed a strong association between higher serum vitamin D levels and a lower risk of bladder, breast, colon, endometrial, esophageal, gallbladder, kidney, ovarian, pancreatic, rectal, stomach, and vulvar cancers, as well as Hodgkin’s and non-Hodgkin’s lymphomas. The review also uncovered lower risks of metastasis and mortality from cancer in patients with higher levels of vitamin D. While vitamin D levels of 20 ng/ml (50 nmol/L) were adequate for bone and muscle health, reduction of cancer risk and mortality required levels greater than 40 ng/ml (100 nmol/L) and fell further with levels above 50 ng/ml (125 nmol/L). The review cautioned that studies showing no benefit for those taking less than 5,000 IU per day might be misleading. [Wimalawansa SJ. Vitamin D’s impact on cancer incidence and mortality: a systematic review. Nutrients. 2025 Jul 16;17(14):2333. Doi: 10.3390/nu17142333.] Is this a fair summary of vitamin D benefits for limiting incidence and severity of cancer?138 views0 answers0 votes
141 views0 answers0 votes
124 views0 answers0 votes
116 views0 answers0 votes
150 views0 answers0 votes
165 views0 answers0 votes
148 views0 answers0 votes
114 views0 answers0 votes
142 views0 answers0 votes
238 views0 answers0 votes
193 views0 answers0 votes
234 views0 answers0 votes
173 views0 answers0 votes